Data from a new study published in NEJM Evidence shows promise for personalized use of short term ADT in men with predominantly intermediate-risk prostate cancer. The study involved ArteraAI, a developer of multimodal artificial ...
Jun 30, 2023
0
13
With over 2 million cases in the U.S. since the coronavirus pandemic began in late December, there are now many people who have recovered from COVID-19. At the same, there have been reports of people who continue to have ...
Jun 24, 2020
0
9
Psychedelic drugs are experiencing something of a renaissance. It's no longer a case of turning on, tuning in and dropping out, as the hippy mantra went in the 1960s. Tripping—whether on magic mushrooms, LSD or psychedelic ...
Nov 24, 2022
1
13
New research by academics at the University of Bristol has found evidence that prolonged treatment of synthetic corticosteroid drugs increases adrenal gland inflammation in response to bacterial infection, an effect that ...
Apr 27, 2020
0
7
Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis, an eye disease that accounts for up to 15% of ...
Sep 10, 2019
0
0
People with a certain type of lymphoma will now have access to a targeted cancer drug on the NHS in England.
Mar 22, 2019
0
3
In the weeks since a new Alzheimer's drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and emails about a treatment that has sparked both excitement and skepticism.
Jun 27, 2021
0
4
While medicines are available to relieve withdrawal symptoms in people recovering from opioid addiction, they cause side effects and can maintain the brain changes that led to addiction in the first place, which can lead ...
Apr 7, 2019
0
35
A single research test has the potential to predict which patients treated with immunotherapies—which harness the immune system to attack cancer cells—are likely to have their cancer recur or have severe side effects, ...
Sep 15, 2022
0
54
Senegal is set to continue administering hydroxychloroquine to coronavirus patients, a senior health official said Thursday, after encouraging results for those treated with the venerable anti-malarial drug.
Apr 2, 2020
0
3
